CONTEXT: Announcement of AMCP Foundation award for Best Poster going to real-world studies in cancer and neurological disease, underscoring the importance of capturing and integrating real-world evidence. IMPACT: Low READ Continue Reading
CONTEXT: Commercial announcement of CVS Health joining the push for decentralised clinical trials with the formation of a new business unit. This pharmacy chain is just the latest in a Continue Reading
CONTEXT: An opinion piece on why more RWE is needed on how patients respond to biosimilars in oncology | “More evidence is the tool for persuading oncology providers to switch Continue Reading
CONTEXT: Real world research showing value in rare disease research where RCTs cannot generate the statistical power traditionally needed with so few available patients. New methods to interpret the RWD Continue Reading
IMPACT: Taking insulin and a GLP-1 agonist significantly increases the ability of achievement stable blood sugar levels READ TIME: 2 mins * 1. “Sanofi’s Soliqua combines an insulin with a Continue Reading
Quick Notes: CONTEXT: Japan, Real-World Data IMPACT: Acceptability of RWD in Regulatory Submissions Time to Read = 2 mins Quotes from Source: 1. “TOKYO — Japan’s health ministry will issue Continue Reading
Quick Notes: *Within the report the “conditional marketing authorisations” and “monitoring in real-life” are the “go to” section to see what the post-authorisation obligations were and what the EMA is Continue Reading
